BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 11731446)

  • 1. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation.
    Huang W; Chiquet-Ehrismann R; Moyano JV; Garcia-Pardo A; Orend G
    Cancer Res; 2001 Dec; 61(23):8586-94. PubMed ID: 11731446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4.
    Orend G; Huang W; Olayioye MA; Hynes NE; Chiquet-Ehrismann R
    Oncogene; 2003 Jun; 22(25):3917-26. PubMed ID: 12813465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
    Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
    Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts.
    Woods A; Longley RL; Tumova S; Couchman JR
    Arch Biochem Biophys; 2000 Feb; 374(1):66-72. PubMed ID: 10640397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PR-39 coordinates changes in vascular smooth muscle cell adhesive strength and locomotion by modulating cell surface heparan sulfate-matrix interactions.
    Chon JH; Houston MM; Xu C; Chaikof EL
    J Cell Physiol; 2001 Nov; 189(2):133-43. PubMed ID: 11598898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenascin-C signaling through induction of 14-3-3 tau.
    Martin D; Brown-Luedi M; Chiquet-Ehrismann R
    J Cell Biol; 2003 Jan; 160(2):171-5. PubMed ID: 12527748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan-1 signals independently of beta1 integrins during Raji cell spreading.
    Lebakken CS; McQuade KJ; Rapraeger AC
    Exp Cell Res; 2000 Sep; 259(2):315-25. PubMed ID: 10964499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coregulation of fibronectin signaling and matrix contraction by tenascin-C and syndecan-4.
    Midwood KS; Valenick LV; Hsia HC; Schwarzbauer JE
    Mol Biol Cell; 2004 Dec; 15(12):5670-7. PubMed ID: 15483051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific processing of tenascin-C by the metalloprotease meprinbeta neutralizes its inhibition of cell spreading.
    Ambort D; Brellier F; Becker-Pauly C; Stöcker W; Andrejevic-Blant S; Chiquet M; Sterchi EE
    Matrix Biol; 2010 Jan; 29(1):31-42. PubMed ID: 19748582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synthetic peptide from the heparin-binding domain III (repeats III4-5) of fibronectin promotes stress-fibre and focal-adhesion formation in melanoma cells.
    Moyano JV; Maqueda A; Albar JP; Garcia-Pardo A
    Biochem J; 2003 Apr; 371(Pt 2):565-71. PubMed ID: 12519080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tetraspanin CD9 influences the adhesion, spreading, and pericellular fibronectin matrix assembly of Chinese hamster ovary cells on human plasma fibronectin.
    Cook GA; Wilkinson DA; Crossno JT; Raghow R; Jennings LK
    Exp Cell Res; 1999 Sep; 251(2):356-71. PubMed ID: 10471321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth promoting signaling by tenascin-C [corrected].
    Ruiz C; Huang W; Hegi ME; Lange K; Hamou MF; Fluri E; Oakeley EJ; Chiquet-Ehrismann R; Orend G
    Cancer Res; 2004 Oct; 64(20):7377-85. PubMed ID: 15492259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism.
    Chalkiadaki G; Nikitovic D; Berdiaki A; Sifaki M; Krasagakis K; Katonis P; Karamanos NK; Tzanakakis GN
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1323-31. PubMed ID: 19110070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase beta (RPTPbeta) to tenascin C.
    Adamsky K; Schilling J; Garwood J; Faissner A; Peles E
    Oncogene; 2001 Feb; 20(5):609-18. PubMed ID: 11313993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration.
    Gao Y; Li M; Chen W; Simons M
    J Cell Physiol; 2000 Sep; 184(3):373-9. PubMed ID: 10911369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1.
    Nunes SS; Outeiro-Bernstein MA; Juliano L; Vardiero F; Nader HB; Woods A; Legrand C; Morandi V
    J Cell Physiol; 2008 Mar; 214(3):828-37. PubMed ID: 17879962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenascin-C inhibits oligodendrocyte precursor cell migration by both adhesion-dependent and adhesion-independent mechanisms.
    Kiernan BW; Götz B; Faissner A; ffrench-Constant C
    Mol Cell Neurosci; 1996 Apr; 7(4):322-35. PubMed ID: 8793866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
    Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan-1 supports integrin alpha2beta1-mediated adhesion to collagen.
    Vuoriluoto K; Jokinen J; Kallio K; Salmivirta M; Heino J; Ivaska J
    Exp Cell Res; 2008 Nov; 314(18):3369-81. PubMed ID: 18657535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells.
    Park H; Han I; Kwon HJ; Oh ES
    Cancer Res; 2005 Nov; 65(21):9899-905. PubMed ID: 16267014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.